“PO-80 | Real-World Effectiveness of Atogepant for the Preventive Treatment of Migraine in a Cohort of Multi -Refractory Patients: A Single Center Study: M. De Luca,1 L. Ferraù,1 A. Cafarchio,2 M.S. Adragna,1 M. Autunno1 | 1Unit of Neurology and Neuromuscular Diseases, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy; 2Department of Medicine and Health Sciences ‘Vincenzo Tibero’ DIMES, University of Molise, Campobasso, Italy”. 2025. Confinia Cephalalgica 35 (S1). https://doi.org/10.4081/cc.2025.15904.